Therapeutic agent for corneal disorders
Therapeutic agents which are antagonists or partial agonists of
Therapeutic methods employing mutant human interleukin-3 (IL-3)
Therapeutic methods using fusion proteins between interleukin-3
Therapeutic methods using interleukin-3 (IL-3) human/murine hybr
Therapeutic uses of fusion proteins between mutant IL 4/IL13 ant
Therapeutic uses of il-1 receptor antagonist
Therapeutic uses of IL-3
Therapeutic uses of interleukin-3 (IL-3) multiple mutation polyp
Thionin as an antineoplastic and immunostimulant
Treatment for diseases involving inflammation
Treatment for diseases involving inflammation
Treatment for diseases involving inflammation
Treatment of accelerated atheosclerosis with interleukin-2 recep
Treatment of allograft rejection with IL-2 receptor-specific cyt
Treatment of alzheimer disease by modulation of synapsins
Treatment of cachexia with interleukin 2
Treatment of diabetes
Treatment of hematopoietic disorders with fusion proteins compri
Treatment of hepatitis C virus infections with interleukin-10